Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer. Huang L, Zeng F, Huang P, Ren D, et al. Cancer 2025;131:e70063.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang L, Zeng F, Huang P, Ren D, et al. Mutational landscape and tyrosine kinase inhibitor sensitivity in EGFR L833 and H835 mutated non-small cell lung cancer. Cancer 2025;131:e70063.
PMID: 40886084